Guillain-Barré-like syndrome with serum IgM binding to GalNAc-GD1a ganglioside
Immune/Antibody
W
View full entry on WUSTL Neuromuscular
antibody/gbs.htm#Guillain-Barré-like syndrome with serum IgM binding to GalNA
Overview
From WUSTL NeuromuscularEpidemiology Japanese patients Younger onset: Mean 3rd decade ? Female > Male Clinical Prodrome GI: Campylobacter jejuni (75%) Respiratory: Cytomegalovirus Weakness: Mild; Proximal + Distal Sensory: Paresthesias ± Loss (75%); More common with CMV prodrome Cranial nerves: Facial weakness (27% to 80%); More common with CMV prodrome Recovery: Good at 1 month; Better than with IgG or no antibodies Electrodiagnostic Demyelination in many (38% to 64%) Axonal loss uncommon Serum antibody IgM vs GalNAc-GD1a ganglioside Cross reactive with GM2 ganglioside: 100% with CMV prodrome; 50% with GI prodrome P
Related Conditions
Shared genes"Classic" Guillain-Barré Syndrome
H131GD1A
Acute Immune Polyneuropathies
GD1APATHOLOGY
Acute Motor (Axonal) Neuropathy (AMAN)
IIGQ1BGM1
ACUTE NEUROPATHIES
GD1A
Antibodies vs Glycolipids & Glycoproteins
GM1MAGGQ1B
C. Anti-GM1 Antibodies
GM1IGMGM1LMN
Chronic Immune Demyelinating Neuropathies: Variants
GD1AMOTORGM1
Classification of Acute Immune Neuropathies
GD1A
External Resources
Data sourced from the Washington University Neuromuscular Disease Center. For clinical use, always refer to primary sources.